Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Optimizing Platelet Generation from hiPSCs: Protocol Advance
2026-04-13
This study presents an optimized differentiation scheme for producing functional platelets from human induced pluripotent stem cells (hiPSCs), significantly improving output and reducing costs. The approach integrates higher embryoid body cell input, serum-free medium, and strategic small molecule substitutions, offering a scalable platform for thrombopoiesis research and cell therapy.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Apoptosis Det
2026-04-13
The Annexin V-Cy5/DAPI Apoptosis Kit from APExBIO enables rapid, reliable differentiation of apoptosis and necrosis with a streamlined workflow. Its integration in leukemia research, as demonstrated in recent studies, highlights its power for quantifying programmed cell death and optimizing experimental reproducibility.
-
Functional Constraints of Influenza A NEP via Deep Mutationa
2026-04-12
This study systematically evaluated over 1,800 single amino acid NEP mutations in human influenza A virus (H1N1), revealing that the N-terminal domain is more tolerant to mutation than the C-terminal domain. The findings illuminate NEP’s functional constraints, its influence on viral RNA synthesis, and implications for mammalian adaptation, providing researchers with a high-resolution map for future antiviral and evolutionary studies.
-
MTT in Advanced In Vitro Assays: Principles, Protocols & Pit
2026-04-12
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is the cornerstone for colorimetric cell viability and metabolic activity assays, prized for its quantitative reliability and broad compatibility. This article bridges cutting-edge experimental designs—from nanomedicine to cytotoxicity screening—while delivering actionable troubleshooting and protocol optimization grounded in both recent literature and APExBIO’s high-purity reagent.
-
Metronidazole in Research: OAT3 Inhibition & Microbiota Modu
2026-04-11
Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) offers a unique dual-action profile as a nitroimidazole antibiotic and potent OAT3 inhibitor, enabling precise modulation of drug transport and microbiota-immune interactions in experimental systems. This article delivers actionable workflows, protocol refinements, and troubleshooting strategies to maximize the impact of Metronidazole in advanced translational research.
-
AO/PI Double Staining Kit: Practical Guide for Cell Viabilit
2026-04-11
The AO/PI Double Staining Kit provides a rapid, two-color fluorescence-based solution for distinguishing viable, apoptotic, and necrotic cells in a single assay. This product is suitable for cell biology workflows requiring direct, visualized assessment of cell viability, apoptosis, and necrosis, but is not intended for mechanistic studies beyond membrane integrity or for quantification without microscopy or compatible imaging systems.
-
PA-824: Mechanistic Insights and Translational Impact in Tub
2026-04-10
Explore the mechanistic nuances of PA-824, a leading bicyclic nitroimidazole derivative in tuberculosis research. This article uniquely examines PA-824's dual action, translational potential, and emerging evidence on rational drug combinations.
-
BML-277: Potent and Selective Chk2 Inhibitor for DNA Dama...
2026-04-10
BML-277 stands out as a potent and highly selective Chk2 inhibitor, enabling precision in DNA damage response research and radioprotection of T-cells. Its ATP-competitive mechanism and nanomolar potency streamline workflows, offering reproducible, reliable results in cancer and radiation biology studies.
-
From Macrophage Mechanisms to Mouse Models: Strategic Adv...
2026-04-09
Translational researchers face growing demands for rapid, accurate, and scalable mouse genotyping as the mechanistic complexity of disease models deepens. This thought-leadership article explores how optimizing workflows with tools like the Direct Mouse Genotyping Kit Plus from APExBIO empowers teams to bridge fundamental mechanistic discoveries—such as the role of macrophage EP4 in atherosclerosis progression—with actionable, reproducible genetic validation. We synthesize recent mechanistic findings, highlight experimental best practices, examine the competitive genotyping landscape, and offer strategic guidance for future-ready mouse genetics research.
-
BML-277: Potent and Selective Chk2 Inhibitor for DNA Dama...
2026-04-08
BML-277 is a potent, ATP-competitive, and highly selective Chk2 kinase inhibitor, validated for use in DNA damage response and radioprotection studies. Its nanomolar inhibitory potency and proven ability to rescue T-cells from radiation-induced apoptosis make it a benchmark tool for cancer biology and genome stability research.
-
EdU Imaging Kits (488): High-Sensitivity S-Phase DNA Synt...
2026-04-08
EdU Imaging Kits (488) offer a robust, verifiable method for quantifying S-phase DNA synthesis via click chemistry, providing a high-sensitivity, non-denaturing alternative to BrdU assays. This 5-ethynyl-2’-deoxyuridine cell proliferation assay from APExBIO preserves DNA and cell integrity, enabling reproducible fluorescence microscopy and flow cytometry workflows.
-
Angiotensin II: Potent Vasopressor for Hypertension and V...
2026-04-07
Angiotensin II is the gold-standard octapeptide for modeling hypertension, vascular smooth muscle cell hypertrophy, and inflammatory responses in translational cardiovascular research. APExBIO’s high-purity Angiotensin II (SKU: A1042) enables reproducible experiments, advanced mechanistic insight, and reliable disease modeling, setting the benchmark for peptide hormone research.
-
Direct Mouse Genotyping Kit Plus: Precision DNA Extractio...
2026-04-07
Accelerate and simplify mouse genotyping assays with the Direct Mouse Genotyping Kit Plus—an innovative, purification-free solution for rapid DNA extraction and PCR amplification. Discover how its streamlined protocol and optimized reagents empower advanced applications, from transgene detection to complex lineage tracing in immune microenvironment studies.
-
Optimizing STING Pathway Research with 2'3'-cGAMP (sodium...
2026-04-06
This article presents scenario-driven guidance for biomedical researchers leveraging 2'3'-cGAMP (sodium salt) (SKU B8362) to overcome common experimental challenges in STING pathway studies. By integrating the latest mechanistic insights and real-world Q&A, we highlight how this research-grade cyclic dinucleotide from APExBIO ensures reproducibility, high-affinity signaling, and practical workflow compatibility.
-
AO/PI Double Staining Kit: Precision Cell Viability and A...
2026-04-06
The AO/PI Double Staining Kit enables rapid, dual-fluorescent discrimination of viable, apoptotic, and necrotic cells using Acridine Orange and Propidium Iodide staining. As a gold-standard tool for cell viability assays and apoptosis detection, it provides clear, reproducible results in diverse research contexts. This article synthesizes mechanistic details, validation benchmarks, and precise workflow parameters for optimal use in cell biology and cancer research.